Today: 30 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Salesforce (CRM) stock steadies after AI selloff jitters — what traders are watching next

Salesforce (CRM) stock steadies after AI selloff jitters — what traders are watching next

Salesforce shares edged up 0.1% to $196.54 Wednesday morning after a 7% drop the previous day, as software stocks faced heavy selling on AI disruption fears. Trading volume reached 11.1 million shares, with the stock swinging between $187.29 and $199.64. Investors are watching for Salesforce’s earnings and guidance for signs of demand and AI strategy.
4 February 2026
······
ServiceNow stock steadies after AI disruption scare hits software names again

ServiceNow stock steadies after AI disruption scare hits software names again

ServiceNow shares hovered near $109.77 Wednesday after a 7% drop the previous day, as U.S. software stocks extended losses amid concerns over AI competition. The S&P 500 software and services index has fallen nearly 13% in five sessions. Investors are awaiting executive appearances for signals on demand and competition.
4 February 2026
·········
Why JPMorgan stock is up today: Baird upgrade meets a steeper Treasury curve

Why JPMorgan stock is up today: Baird upgrade meets a steeper Treasury curve

JPMorgan Chase shares rose 0.9% to $317.70 in late-morning New York trading Wednesday, after hitting $318.99 earlier. The 2-year/10-year Treasury spread widened to about 70.8 basis points as traders digested steady auction sizes and warnings of higher future deficits. U.S. private payrolls increased by 22,000 in January, missing forecasts. JPMorgan is in talks with investors on a new frontier-market bond index, sources said.
4 February 2026
·
Exxon Mobil stock price today: XOM nears fresh highs as oil steadies and dividend date looms

Exxon Mobil stock price today: XOM nears fresh highs as oil steadies and dividend date looms

Exxon Mobil shares rose 1.6% to $146.02 by late morning Wednesday, near their session high, as oil prices steadied after U.S.-Iran tensions flared in the Strait of Hormuz. Brent crude edged up to $67.38 a barrel. Traders are watching U.S.-Iran talks in Oman set for Friday and Exxon’s dividend record date on Feb. 12. Volume in Exxon shares more than doubled its 50-day average Tuesday.
4 February 2026
····
Western Digital stock slides nearly 9% in New York trade as buyback bounce fades

Western Digital stock slides nearly 9% in New York trade as buyback bounce fades

Western Digital shares fell about 9% to $264.17 by late morning Wednesday, after the company boosted its buyback authorization by $4 billion on Tuesday. Seagate and Micron also dropped as memory and storage stocks sold off. The moves followed Western Digital’s new pitch to capitalize on AI-driven data-center demand. Tech stocks broadly declined, with AMD sliding over 12% after a revenue warning.
4 February 2026
··
PayPal stock price today: PYPL slips again as CEO shake-up rattles analysts

PayPal stock price today: PYPL slips again as CEO shake-up rattles analysts

PayPal shares fell about 1% to near $41 early Wednesday after a CEO shakeup and lower profit outlook for 2026. The company reported Q4 net revenue up 4% to $8.7 billion and payment volume up 9% to $475.1 billion. Multiple brokers cut ratings and price targets, citing weak branded checkout growth and uncertainty over the leadership transition. Jamie Miller will serve as interim CEO until Enrique Lores takes over March 1.
4 February 2026
·
Oracle stock slides as $25 billion bond sale settles and a $20 billion share plan looms

Oracle stock slides as $25 billion bond sale settles and a $20 billion share plan looms

Oracle shares fell 1.9% to $151.71 Wednesday after the company announced a $25 billion bond sale and a $20 billion at-the-market share program. The fundraising aims to support Oracle’s cloud expansion but raised investor concerns over dilution and debt. The bond offering settles Feb. 4, with maturities ranging from 2029 to 2066. Oracle also plans a $5 billion mandatory convertible preferred stock sale.
4 February 2026
·
GOOG stock price drops as Alphabet earnings loom and DOJ appeal adds fresh antitrust risk

GOOG stock price drops as Alphabet earnings loom and DOJ appeal adds fresh antitrust risk

Alphabet’s Class C shares fell 1.8% to $334.62 by midmorning Wednesday, hitting a new intraday low ahead of its earnings report. The drop followed a global selloff in software and data-analytics stocks after Anthropic’s Claude Cowork launch. Alphabet’s earnings call is set for 4:30 p.m. EST, with analysts watching for updates on AI and data center spending. Regulators said they will appeal remedies in the ongoing Google search monopoly case.
4 February 2026
··
AMD stock price slides 14% after outlook flags a slower quarter — and AI nerves bite

AMD stock price slides 14% after outlook flags a slower quarter — and AI nerves bite

AMD shares fell 14.2% to $207.81 in New York after the company warned of a 5% sequential drop in first-quarter revenue, citing about $100 million in China chip sales. The stock marked its steepest single-day loss in months. Fourth-quarter revenue rose 34% to $10.27 billion, with data center sales hitting a record $5.4 billion. Investors await Nvidia’s Feb. 25 earnings for further signals on AI hardware demand.
4 February 2026
··
Broadcom stock slides as AI jitters hit chipmakers; AVGO eyes March 4 earnings

Broadcom stock slides as AI jitters hit chipmakers; AVGO eyes March 4 earnings

Broadcom shares fell 2.3% to $312.87 Wednesday, tracking declines in chip stocks after AMD’s weak sales forecast reignited doubts about AI hardware demand. The drop followed a 3.3% slide Tuesday, despite Broadcom unveiling new enterprise Wi-Fi 8 products. Software and IT services stocks also slid globally after Anthropic’s AI agent launch. Broadcom will report fiscal Q1 results on March 4.
4 February 2026
·····
Silver price snaps back toward $90 after crash; traders brace for more swings

Silver price snaps back toward $90 after crash; traders brace for more swings

Spot silver surged nearly 6% to about $90 an ounce Wednesday, recovering from last week’s record drop triggered by CME margin hikes and the Fed chair nomination. Spot gold rose 2% to $5,047 an ounce. Volatility in silver remains high, with realized volatility hitting 186% on Friday. Markets now await ECB and BoE decisions, while U.S. data releases face disruptions.
4 February 2026
Dow Jones today: Dow edges higher as Lilly, Super Micro cushion Wall Street after AI software rout

Dow Jones today: Dow edges higher as Lilly, Super Micro cushion Wall Street after AI software rout

The Dow rose 0.4% at Wednesday’s open, led by gains in Eli Lilly and Super Micro Computer after strong earnings. The Nasdaq slipped 0.27% as investors remained wary of software stocks amid AI disruption fears. ADP reported U.S. private payrolls rose by just 22,000 in January, missing forecasts. President Trump signed a bill ending the partial government shutdown, but funding for Homeland Security runs out February 13.
4 February 2026
··
Bitcoin price slips toward $74,000 as ETF flows whipsaw and Warsh Fed pick keeps traders wary

Bitcoin price slips toward $74,000 as ETF flows whipsaw and Warsh Fed pick keeps traders wary

Bitcoin fell nearly 4% Wednesday, trading near $74,389 after dipping as low as $72,971. Ether dropped about 4% to $2,169. Crypto-linked stocks, including Coinbase and Marathon Digital, also declined. Uncertainty grew after President Trump nominated Kevin Warsh to lead the Fed, while weak U.S. jobs data and volatile ETF flows added to market pressure.
4 February 2026
······
1 … 147 148 149 150 151 … 726

Stock Market Today

  • 1 Stock to Buy and 2 to Avoid Near 52-Week Highs: United Therapeutics Shines, Tilly's and Bristol-Myers Squibb Falter
    March 30, 2026, 9:49 AM EDT. Stocks near their 52-week highs often reflect strong momentum, but not all sustain success. United Therapeutics (NASDAQ: UTHR) stands out with 16.9% revenue growth, a robust 34.2% free cash flow margin, and improving capital returns, signaling solid market positioning. Conversely, Tilly's (NYSE: TLYS) posts a 197% one-month gain but struggles with decreasing same-store sales and a 55.2% annual drop in earnings per share (EPS), raising valuation concerns at a forward EV-to-EBITDA of 92.6x. Bristol-Myers Squibb (NYSE: BMY) faces growth constraints with only 2.6% revenue increase over five years and shrinking operating margins, trading at 9.5x forward price-to-earnings (P/E). Investors should weigh United Therapeutics' fundamentals against challenges in Tilly's and BMY before acting.
Go toTop